6618.HK JD Health International Inc.
HKSEHealthcareAs of 2026-08-25 15:42
Why 6618.HK matters now
JD Health International Inc. (6618.HK) is a Hong Kong stock in Healthcare. The latest InvestLog snapshot shows HK$37.74 with +1.13% on the session and HK$121.19B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 16.85, gross margin 25.3%, and operating margin 6.1%.
Valuation
P/E (TTM)
16.85
PEG
—
P/B
1.67
P/S
1.32
EV/EBITDA
16.78
DCF Value
—
FCF Yield
8.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
25.3%
Operating Margin
6.1%
Net Margin
7.9%
ROE
10.2%
ROA
7.3%
ROIC
6.4%
Listing Info
Market
Hong Kong
Exchange
HKSE
Currency
HKD
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
CN
JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.